Literature DB >> 16864745

Role of extracellular superoxide dismutase in hypertension.

Maria Carolina Gongora1, Zhenyu Qin, Karine Laude, Ha Won Kim, Louise McCann, J Rodney Folz, Sergey Dikalov, Tohru Fukai, David G Harrison.   

Abstract

We previously found that angiotensin II-induced hypertension increases vascular extracellular superoxide dismutase (ecSOD), and proposed that this is a compensatory mechanism that blunts the hypertensive response and preserves endothelium-dependent vasodilatation. To test this hypothesis, we studied ecSOD-deficient mice. ecSOD(-/-) and C57Blk/6 mice had similar blood pressure at baseline; however, the hypertension caused by angiotensin II was greater in ecSOD(-/-) compared with wild-type mice (168 versus 147 mm Hg, respectively; P<0.01). In keeping with this, angiotensin II increased superoxide and reduced endothelium-dependent vasodilatation in small mesenteric arterioles to a greater extent in ecSOD(-/-) than in wild-type mice. In contrast to these findings in resistance vessels, angiotensin II paradoxically improved endothelium-dependent vasodilatation, reduced intracellular and extracellular superoxide, and increased NO production in aortas of ecSOD(-/-) mice. Whereas aortic expression of endothelial NO synthase, Cu/ZnSOD, and MnSOD were not altered in ecSOD(-/-) mice, the activity of Cu/ZnSOD was increased by 80% after angiotensin II infusion. This was associated with a concomitant increase in expression of the copper chaperone for Cu/ZnSOD in the aorta but not in the mesenteric arteries. Moreover, the angiotensin II-induced increase in aortic reduced nicotinamide-adenine dinucleotide phosphate oxidase activity was diminished in ecSOD(-/-) mice as compared with controls. Thus, during angiotensin II infusion, ecSOD reduces hypertension, minimizes vascular superoxide production, and preserves endothelial function in resistance arterioles. We also identified novel compensatory mechanisms involving upregulation of copper chaperone for Cu/ZnSOD, increased Cu/ZnSOD activity, and decreased reduced nicotinamide-adenine dinucleotide phosphate oxidase activity in larger vessels. These compensatory mechanisms preserve large vessel function when ecSOD is absent in hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864745     DOI: 10.1161/01.HYP.0000235682.47673.ab

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  86 in total

Review 1.  Redox regulation of mitochondrial function.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2012-02-03       Impact factor: 8.401

2.  Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury.

Authors:  Markus P Schneider; Jennifer C Sullivan; Paul F Wach; Erika I Boesen; Tatsuo Yamamoto; Tohru Fukai; David G Harrison; David M Pollock; Jennifer S Pollock
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

3.  Reactive oxygen species, NADPH oxidases, and hypertension.

Authors:  Srinivasa Raju Datla; Kathy K Griendling
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

Review 4.  Measurement of reactive oxygen species in cardiovascular studies.

Authors:  Sergey Dikalov; Kathy K Griendling; David G Harrison
Journal:  Hypertension       Date:  2007-02-12       Impact factor: 10.190

5.  Amelioration of salt-induced vascular dysfunction in mesenteric arteries of Dahl salt-sensitive rats by missense mutation of extracellular superoxide dismutase.

Authors:  Andreas M Beyer; Gabor Raffai; Brian D Weinberg; Katherine Fredrich; Matthew S Rodgers; Aron M Geurts; Howard J Jacob; Melinda R Dwinell; Julian H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

6.  Time-course and mechanisms of restored vascular relaxation by reduced salt intake and angiotensin II infusion in rats fed a high-salt diet.

Authors:  Scott T McEwen; James R Schmidt; Lewis Somberg; Lourdes de la Cruz; Julian H Lombard
Journal:  Microcirculation       Date:  2009-02-23       Impact factor: 2.628

7.  Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction.

Authors:  Zhongbing Lu; Xin Xu; Xinli Hu; Guangshuo Zhu; Ping Zhang; Elza D van Deel; Joel P French; John T Fassett; Tim D Oury; Robert J Bache; Yingjie Chen
Journal:  Hypertension       Date:  2007-11-12       Impact factor: 10.190

Review 8.  Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.

Authors:  Michael V Holmes; Mika Ala-Korpela; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2017-06-01       Impact factor: 32.419

9.  Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system.

Authors:  Heinrich E Lob; Paul J Marvar; Tomasz J Guzik; Shraya Sharma; Louise A McCann; Cornelia Weyand; Frank J Gordon; David G Harrison
Journal:  Hypertension       Date:  2009-12-14       Impact factor: 10.190

Review 10.  Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD.

Authors:  Zhenyu Qin; Krzysztof J Reszka; Tohru Fukai; Neal L Weintraub
Journal:  Transl Res       Date:  2007-11-08       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.